罗氟司特最新公布价格表

Roflumilast is a phosphodiesterase-4 (PDE4) inhibitor, mainly used to treat chronic obstructive pulmonary disease (COPD). Its price information has important reference value for patients' medication selection. This article details the latest international market price data, and introduces standardized medication preparations and contraindications to provide comprehensive medication guidance for COPD patients.

The latest announced price of roflumilast

There are obvious differences in pricing in different countries and regions. Understanding this price information can help patients make economical and reasonable medication choices.

British AstraZeneca German version

Roflumilast sold in the German market is produced by British AstraZeneca, and the reference price of 500μg*30 tablets is US$233 per box. The price of a large package of 90 pieces is about US$391, which is relatively more cost-effective.

British AstraZeneca Hong Kong version

The Hong Kong market also sells Roflumilast produced by British AstraZeneca, with a reference price of about US$134 for 500μg*30 tablets. The price is more favorable than the German version, making it the choice of many Asian patients.

Price Differences

Price differences in different regions are mainly due to local drug pricing policies, tax systems and market competition. As a developed country, Germany has generally higher drug prices.

Patients can choose the most suitable purchasing channel and packaging specifications based on their own economic conditions and medication needs.

Preparation for roflumilast administration

Patients need to strictly follow the following specifications.

Pre-medication evaluation

Before starting treatment, a comprehensive pulmonary function test and clinical evaluation are required to confirm the diagnosis of COPD and disease severity, and to assess whether there are any contraindications to medication.

Dose selection

The standard recommended dose is 500 μg orally once daily. The dosage may need to be adjusted for certain groups of people, and medical advice must be strictly followed.

Dose time

It is recommended to take it at the same time every day, preferably on an empty stomach in the morning to maintain a stable blood concentration.

Standard medication preparation can help patients reduce the occurrence of adverse reactions.

Contraindications of roflumilast

Understanding medication contraindications is crucial to prevent serious adverse reactions. The following groups of people are prohibited from using roflumilast.

Patients with hepatic insufficiency

It is contraindicated in patients with moderate to severe hepatic insufficiency (Child-Pugh class B or C). Patients with mild hepatic impairment should use it with caution and enhanced monitoring.

Special groups

Contraindicated for pregnant and lactating women. Safety for children and adolescents under 18 years of age has not been established and use is not recommended.

Drug interactions

Concomitant use with strong CYP3A4 inhibitors may increase the risk of adverse reactions. Roflumilast should be avoided when such medication is needed.

Strictly grasp the contraindications to medication and standardize medication under the guidance of a doctor to maximize medication safety.